Device Trial Radar · NCT05058430
SaliPen Human Factors Study for OTC Labeling
Last checked: Nov 20, 2026Latest source record: Jan 9, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
24
Actual
Start
Sep 16, 2021
Primary completion
Nov 18, 2021
Study completion Nov 18, 2021
Sponsor
- Lead sponsor
- Saliwell Ltd.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Indiana University
- First posted
- Sep 27, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This Human Factors Validation Testing will assess user interactions to verify the capability of potential users to assess if the study product fits their needs and if they can use it correctly based on the provided Information For User (IFU)? More specifically, this is a non-comparative case series study and is subdivided into two major parts. Those parts are: 1. Phase I: aimed at testing if, based on the IFU, the potential subjects can decide whether the study product is or is not appropriate to treat their condition and, 2. Phase II: aimed at assessing whether the users can use the study product correctly without counseling by a health care provider.
Conditions
- Xerostomia
Interventions
Electrical salivary stimulator system assigned to subjects with xerostomiaDevice
SaliPen is an electrical salivary stimulator system, intended to electrically stimulate a relative increase in saliva production. It is an intraoral device indicated for use in patients with xerostomia (dry mouth).
No Electrical salivary stimulator system assigned to subjects without xerostomiaDevice
SaliPen is an electrical salivary stimulator system, intended to electrically stimulate a relative increase in saliva production. It is an intraoral device indicated for use in patients with xerostomia (dry mouth).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Who Appropriately Will Self-select the Study Product for Use Under Simulated OTC Conditions [Phase I]Time frame: One hour
1 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Indiana University School of Dentistry, Oral Health Research Institute
Indianapolis, Indiana
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.